Hong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by December

If clinical trials are successful, Sinopharm’s new vaccine could join O jabs being developed by BioNTech, Moderna.

Share this:

What do you think?

Leave a Reply

Your email address will not be published. Required fields are marked *

Written by Headlines

Mainstream media is often "Fake News." Nevertheless, one needs to see what others are seeing and then read with discernment.

China calls on Myanmar’s junta to hold talks with opponents

Russia warns Finland against NATO border base